Indivior Expects FY23 Net Revenue Of $1.03B-$1.09B Vs. Consensus Of $1.05B; Adjusted Gross Margin Of Low Mid 80% Range; Adjusted Operating Income Of $212M
Portfolio Pulse from Benzinga Newsdesk
Indivior has updated its FY23 net revenue forecast to $1.03B-$1.09B, in line with the consensus of $1.05B. The company expects an adjusted gross margin in the low to mid 80% range and an adjusted operating income of $212M. The company's SUBLOCADE and PERSERIS products are expected to see significant revenue growth, while the market share of SUBOXONE Film is expected to decline due to increased competition.
November 09, 2023 | 8:27 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Indivior's updated FY23 net revenue forecast aligns with the consensus, indicating stable performance. However, increased competition could impact the market share of its SUBOXONE Film product.
Indivior's updated revenue forecast is in line with the consensus, indicating that the market's expectations are being met. However, the expected decline in market share for SUBOXONE Film due to increased competition could potentially impact the company's overall performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100